Vice President EDPL Immuno-Oncology MD

The primary responsibilities of this role, Vice President Early Development Portfolio Management (EDPL), are to: 

•      Set the vision and strategy for portfolio pipeline of the Immuno-Oncology (IO) platform;

•      Prioritize and make strategy recommendations on assigned assets and portfolio of the platform including on strategic external partnerships for new areas such as Immuno-Oncology or for combination development;

•      Design together with Global Program Teams (GPTs) a ‘state-of-the-art’ product development strategy for the IO platform and compose assets based on patient, regulatory and commercial needs as well as delivering on complex technical challenges;

•      Deliver portfolio program milestones in a timely, cost-effective and high quality fashion from D3 to First in Man (FIM), through efficacy signal generation in Phase I/II (and as necessary formal Proof of Concept studies) and thereafter for delivery of Early Development contributions to life cycle management. This includes de-risking of programs and investments as early as possible;

•      Liaise with Research, Late Development, and Commercial to ensure smooth project transitions into the late development phase, as appropriate, and alignment on the project objectives and deliverables including positioning of assets covering multitude of different Mechanism of Action (MoA) across many tumor types;

•      Be fully responsible as a physician for all medical/clinical aspects for assigned drug candidates until Proof of Concept (PoC);

•      Be responsible for the ongoing benefit/risk assessment of drug candidates and for taking relevant actions and decisions as appropriate, based on the thorough medical/clinical understanding;

•      Ensure appropriate representation of the GPT to governance and other decision-making bodies;

•      Ensure timely and transparent and objective communications about program status and issues between GPT and management;

•      Constantly review the market environment in order to ensure the program’s strategy is meeting patient, regulatory and commercial needs;

•      Exploit scientific advances and evolving development paradigms to ensure state-of-the-art programs for their assets;

•      Has key understanding of regulatory agencies policies and procedures that impact their development assets;

•      Drive technical reviews for the programs in the portfolio;

•      Oversee the development of the Target Product Profile (TPP) and revisions thereof;

•      Network with Key Opinion Leaders and maintain effective external scientific advisory boards which is especially important for new territories such as Immuno-Oncology;

•      Drive overall R&D assessment and provide medical assessment of in- and out-licensing opportunities of development projects;

•      Actively seek opportunities to represent Bayer in various external forums and panels, such as industry consortia, government-industry panels, professional societies and patient-focused groups;

•      Create and lead motivated, committed and engaged sGPMs/ECLs and GPTs;

•      Model and expect effective team behavior to achieve the project.

 

WHO YOU ARE

 

Your success will be driven by your demonstration of our LIFE values.  More specifically related to this position, Bayer seeks an incumbent who possesses the following:

 

Required Qualifications:

 

•      Highly successful M.D. with extensive professional and academic experience;

•      At least 7 years’ experience in developing compounds through early development phases;

•      Proven and broad knowledge in the field of immuno-oncology;

•      Current knowledge and experience of drug development in patients;

•      Knowledge of the whole R&D process and the key drivers for success;

•      Strong understanding of the elements of drug development programs;

•      Track record of achievement in a relevant discipline within pharmaceutical development;

•      Current knowledge of regulatory review and responses;

•      Exposure to and understanding of commercial considerations in relation to drug development;

•      Evidence of ability to lead and manage a team to deliver to time, cost and quality requirements;

•      Able to manage diverse activities to deliver milestones according to set budgets;

•      Sets priorities and organizes a team effectively;

•      Able to manage and develop both direct reports and matrixed team members, including performance management and change management;

•      Capable of recognizing when team interventions are required to enhance team effectiveness and utilizing a variety of management and influencing techniques to ensure delivery of the program;

•      Effective resource management including demonstrated fiscal responsibility;

•      Evidence of ability to lead and implement continuous improvement;

•      Capable of managing and developing team members from diverse technical backgrounds, including deep technical / scientific expertise;

•      Creates and sustains a collaborative, innovative and effective team;

•      Compliant with business processes whilst retaining a flexible entrepreneurial and open-minded approach to new and creative ideas;

•      Handles conflict constructively;

•      Makes sound decisions after thorough consideration of the options;

•      Able to anticipate issues related to the delivery of the project goals and manage risks;

•      Works constructively with team members and platform line leaders to achieve objectives;

•      Driven by the challenge of speedier and more cost-efficient drug development;

•      Exhibits good leadership behaviors;

•      Sustain Focus on Performance;

•      Sets the right priorities, seizes strategic opportunities, adheres to high standards, and focuses always on our customers;

•      Creates an environment where colleagues are included and encouraged to contribute ideas to improve results and enhance performance an ensures that other managers do the same;

•      Listens actively and encourages contribution to get differing points of view and develop the best ideas to meet business challenges;

•      Anticipates strategically and adapts to change – both in the external environment and within the company;

•      Takes initiative and plans for better ways to operate;

•      Empowers people to act to respond to business challenges and sustain success;

•      Offers productive feedback, collaborates with colleagues on development plans, skillfully listens, and coaches and mentors;

•      Contributes to the success of an organization as a whole, communicates and collaborates effectively with other departments and across divisions, utilizes and supports governance systems, and recognizes that success is mutual and cannot come at the expense of other parts of the organization.

Preferred Qualifications:

•      Board-certification in oncology or hematology/oncology or Immunology;

•      Experience in late development phases including leading of one or more agents to a regulatory approval.

YOUR APPLICATION     

Bayer offers a wide variety of competitive compensation and benefits programs. If you meet the requirements of this unique opportunity, and you have the "Passion to Innovate" and the "Power to Change", we encourage you to apply now. To all recruitment agencies: Bayer does not accept unsolicited third party resumes.

Bayer is an Equal Opportunity Employer/Disabled/Veterans

    

Bayer is committed to providing access and reasonable accommodations in its application process for individuals with disabilities and encourages applicants with disabilities to request any needed accommodation(s) using the contact information below.    

       

Location: United States : New Jersey : Whippany     

Division: Pharmaceuticals